Crossmark

A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment

Published Online: 2023-05-26

Published Print: 2023-06

Authors

Yang, Xianguang

Zhang, Baohong https://orcid.org/0000-0002-9308-4340
License Information

Text and Data Mining valid from 2023-05-26

Version of Record valid from 2023-05-26
More Information

Article History

Received: 2 April 2023

Revised: 17 May 2023

Accepted: 18 May 2023

First Online: 26 May 2023

Declarations

:

: Not applicable.

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current